BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 21624470)

  • 1. Pharmacokinetic and chemoprevention studies on tea in humans.
    Chow HH; Hakim IA
    Pharmacol Res; 2011 Aug; 64(2):105-12. PubMed ID: 21624470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Green tea polyphenols and cancer chemoprevention: multiple mechanisms and endpoints for phase II trials.
    Moyers SB; Kumar NB
    Nutr Rev; 2004 May; 62(5):204-11. PubMed ID: 15212320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The chemistry and biotransformation of tea constituents.
    Sang S; Lambert JD; Ho CT; Yang CS
    Pharmacol Res; 2011 Aug; 64(2):87-99. PubMed ID: 21371557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioavailability issues in studying the health effects of plant polyphenolic compounds.
    Yang CS; Sang S; Lambert JD; Lee MJ
    Mol Nutr Food Res; 2008 Jun; 52 Suppl 1():S139-51. PubMed ID: 18551457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivery of tea polyphenols to the oral cavity by green tea leaves and black tea extract.
    Lee MJ; Lambert JD; Prabhu S; Meng X; Lu H; Maliakal P; Ho CT; Yang CS
    Cancer Epidemiol Biomarkers Prev; 2004 Jan; 13(1):132-7. PubMed ID: 14744744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic issues concerning cancer prevention by tea catechins.
    Yang CS; Wang H
    Mol Nutr Food Res; 2011 Jun; 55(6):819-31. PubMed ID: 21538856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals.
    Chow HH; Hakim IA; Vining DR; Crowell JA; Ranger-Moore J; Chew WM; Celaya CA; Rodney SR; Hara Y; Alberts DS
    Clin Cancer Res; 2005 Jun; 11(12):4627-33. PubMed ID: 15958649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical development plan: tea extracts. Green tea polyphenols. Epigallocatechin gallate.
    J Cell Biochem Suppl; 1996; 26():236-57. PubMed ID: 9154181
    [No Abstract]   [Full Text] [Related]  

  • 9. Green tea catechins and their metabolites in human skin before and after exposure to ultraviolet radiation.
    Clarke KA; Dew TP; Watson RE; Farrar MD; Osman JE; Nicolaou A; Rhodes LE; Williamson G
    J Nutr Biochem; 2016 Jan; 27():203-10. PubMed ID: 26454512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGCG, green tea polyphenols and their synthetic analogs and prodrugs for human cancer prevention and treatment.
    Chen D; Wan SB; Yang H; Yuan J; Chan TH; Dou QP
    Adv Clin Chem; 2011; 53():155-77. PubMed ID: 21404918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E.
    Chow HH; Cai Y; Alberts DS; Hakim I; Dorr R; Shahi F; Crowell JA; Yang CS; Hara Y
    Cancer Epidemiol Biomarkers Prev; 2001 Jan; 10(1):53-8. PubMed ID: 11205489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigallocatechin 3-gallate and green tea catechins: United they work, divided they fail.
    Bode AM; Dong Z
    Cancer Prev Res (Phila); 2009 Jun; 2(6):514-7. PubMed ID: 19470792
    [No Abstract]   [Full Text] [Related]  

  • 13. Green tea polyphenols and metabolites in prostatectomy tissue: implications for cancer prevention.
    Wang P; Aronson WJ; Huang M; Zhang Y; Lee RP; Heber D; Henning SM
    Cancer Prev Res (Phila); 2010 Aug; 3(8):985-93. PubMed ID: 20628004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenging the effectiveness of green tea in primary and tertiary cancer prevention.
    Fujiki H; Imai K; Nakachi K; Shimizu M; Moriwaki H; Suganuma M
    J Cancer Res Clin Oncol; 2012 Aug; 138(8):1259-70. PubMed ID: 22699930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review: green tea polyphenols in chemoprevention of prostate cancer: preclinical and clinical studies.
    Khan N; Adhami VM; Mukhtar H
    Nutr Cancer; 2009; 61(6):836-41. PubMed ID: 20155624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies.
    Williamson G; Manach C
    Am J Clin Nutr; 2005 Jan; 81(1 Suppl):243S-255S. PubMed ID: 15640487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of inhibition of carcinogenesis by tea.
    Yang CS; Chung JY; Yang GY; Li C; Meng X; Lee MJ
    Biofactors; 2000; 13(1-4):73-9. PubMed ID: 11237203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The chemo-protector effects of tea and its components].
    González de Mejía E
    Arch Latinoam Nutr; 2003 Jun; 53(2):111-8. PubMed ID: 14528600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Green tea polyphenols for prostate cancer chemoprevention: a translational perspective.
    Johnson JJ; Bailey HH; Mukhtar H
    Phytomedicine; 2010 Jan; 17(1):3-13. PubMed ID: 19959000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multitargeted therapy of cancer by green tea polyphenols.
    Khan N; Mukhtar H
    Cancer Lett; 2008 Oct; 269(2):269-80. PubMed ID: 18501505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.